These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 9781987

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cytokine expression in otitis media with effusion. Tumor necrosis factor soluble receptor.
    Maxwell K, Leonard G, Kreutzer DL.
    Arch Otolaryngol Head Neck Surg; 1997 Sep; 123(9):984-8. PubMed ID: 9305251
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Proinflammatory and immunoregulatory cytokines in the middle ear effusions.
    Skotnicka B, Hassmann E.
    Int J Pediatr Otorhinolaryngol; 2008 Jan; 72(1):13-7. PubMed ID: 17976828
    [Abstract] [Full Text] [Related]

  • 6. Immunologic characteristics of cytokines in otitis media with effusion.
    Himi T, Suzuki T, Kodama H, Takezawa H, Kataura A.
    Ann Otol Rhinol Laryngol Suppl; 1992 Oct; 157():21-5. PubMed ID: 1416648
    [Abstract] [Full Text] [Related]

  • 7. Demonstration of interleukin 6 in middle ear effusions.
    Yellon RF, Leonard G, Marucha P, Sidman J, Carpenter R, Burleson J, Carlson J, Kreutzer D.
    Arch Otolaryngol Head Neck Surg; 1992 Jul; 118(7):745-8. PubMed ID: 1627297
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tumor necrosis factor-alpha and interleukin-1beta levels in recurrent and persistent otitis media with effusion.
    Yetiser S, Satar B, Gumusgun A, Unal F, Ozkaptan Y.
    Otolaryngol Head Neck Surg; 2002 Apr; 126(4):417-22. PubMed ID: 11997784
    [Abstract] [Full Text] [Related]

  • 15. Compositional differences between bilateral middle ear effusions in otitis media with effusion: evidence for a different etiology?
    Johnson IJ, Brooks T, Hutton DA, Birchall JP, Pearson JP.
    Laryngoscope; 1997 May; 107(5):684-9. PubMed ID: 9149175
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cytokines, immunoglobulins, and bacterial pathogens in middle ear effusions.
    Yellon RF, Doyle WJ, Whiteside TL, Diven WF, March AR, Fireman P.
    Arch Otolaryngol Head Neck Surg; 1995 Aug; 121(8):865-9. PubMed ID: 7619411
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. How does endotoxin trigger inflammation in otitis media with effusion?
    Schousboe LP, Ovesen T, Eckhardt L, Rasmussen LM, Pedersen CB.
    Laryngoscope; 2001 Feb; 111(2):297-300. PubMed ID: 11210878
    [Abstract] [Full Text] [Related]

  • 20. Role of macrophage migration inhibitory factor in otitis media with effusion in adults.
    Kariya S, Okano M, Aoji K, Kosaka M, Chikumoto E, Hattori H, Yuen K, Nishioka S, Nishioka K, Nishizaki K.
    Clin Diagn Lab Immunol; 2003 May; 10(3):417-22. PubMed ID: 12738641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.